Joseph Frattaroli - Cheif Financial Officer at Inhibikase Therapeutics, Inc.

Insider Transactions and Holdings

Entity Type
Individual
Role
Cheif Financial Officer
Issuer Symbol
IKT on Nasdaq
All Insider Reports
All Insider Reports

There are no Buy or Sell transactions made by Joseph Frattaroli since 14 Mar 2025

Holdings reported by Joseph Frattaroli for Inhibikase Therapeutics, Inc.

Security Num Shares Value Price $ Transaction Date Ownership Underlying Class Underlying Amount
Common Stock 48,091 $38,473 $0.8000 01 Mar 2023 Direct
Stock Option (right to buy) 90,000 01 Mar 2023 Direct Common Stock

Transactions reported by Joseph Frattaroli for Inhibikase Therapeutics, Inc.

Sym Class Transaction % Value $ * Price $ Shares Shares After Date Ownership
* An asterisk sign (*) next to the price indicates that the price is likely invalid.